James Cowper Kreston have successfully advised Curo Consulting Ltd on its disposal to Envision Pharma Group

James Cowper Kreston are pleased to announce the acquisition of Curo Consulting Ltd (“Curo” or “the Target”) by Envision Pharma Group (“Envision” or “the Acquirer”). The Corporate Finance team provided lead advisory services to Curo.

Curo specialises in enabling biopharma companies to communicate with payers, policy makers, and providers ‘in their language’. With its UK head office in Marlow, Buckinghamshire, Curo’s services are supported by innovative HEOR and Market Access software including LENSTM (Literature and Evidence Navigation System) and Evidence NavigatorTM purpose-built technologies, which will augment Envision’s range of industry-leading technology solutions.

Envision’s CEO, Brian Hepburn, said: “The addition of Curo to the Envision Pharma Group augments our existing Market Access capabilities and further cements our core tenet of marrying expertise and technology to become the leading international Medical Affairs agency. In the current biopharma landscape, value demonstration is an essential part of the evidence communication package. Curo’s consulting expertise and software products will ensure that we offer optimal evidence communications strategies to our clients.”

Curo CEO, Christopher O’Neill, said: “We are absolutely delighted to become part of Envision. Curo has spent the past 3 years building and proving the impact of a series of innovative digital platforms to support Value Curation in HEOR and Market Access. In Envision, we have found a partner with the same commitment to combining services with supporting technology. Philosophically, this is incredibly important. Practically, the size and reach of the Envision group will give us the opportunity to build out a scalable infrastructure which will enable us to service our clients with more comprehensive end-to-end Value Curation solutions.”

Jonathan Mowll, Managing Director of Curo, said: “Stuart and the team at James Cowper Kreston provided experience and professionalism to guide us through the process to complete the acquisition of Curo. Strong connections in the pharma network brought in potential acquirers and their sound accounting and negotiating skills meant that we felt in safe hands throughout the process. We wouldn’t hesitate in recommending them to others."

Stuart Williams, Corporate Finance Director at James Cowper Kreston, added: “We are delighted to have provided invaluable assistance with the sale of Curo to Envision. We believe that Envision is a great home for the business to continue its impressive growth and wish them every success in the future.

 Law firm Moorcrofts LLP provided legal advice to the shareholders of Curo Consulting Ltd.

For more information on our award winning range of corporate finance services, please call Stuart Williams on +44 (0)118 9590261.